The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Background/Aims: The National Liver Cancer Surveillance Program (NLCSP) was established in 2003 to reduce the socioeconomic burden imposed by liver cancer (LC). We aimed to investigate the effectiveness of the NLCSP in South Korea with respect to survival benefits and cost, after adjusting for various confounding factors. Methods: We used the National Health Insurance Service claims data linked with the NLCSP from 2004 to 2015. The Cox proportional hazard model and generalized linear model were used to determine the effects of the NLCSP on the early detection of LC, survival, and medical costs. Results: From 2006 to 2010, 66,632 patients (surveillance group: 10,527 and no surveillance group: 56,105) newly diagnosed with LC were included in the study. The odds of the early detection of LC was 1.82 (95% confidence interval [CI], 1.73 to 1.93) times higher among patients who participated in the NLCSP once within the 2-year period prior to the diagnosis of LC than among those who did not participate in the surveillance program. The mortality rate of patients who participated in the NLCSP was 22.0% lower (hazard ratio, 0.78; 95% CI, 0.76 to 0.80) than that of those who did not participate. When compared with the group who did not participate in surveillance, the group who participated in the NLCSP had higher total medical costs; however, their cost per day was lower after adjustment during the follow-up period. Conclusions: This study highlights the survival benefit in patients who participated in the NLCSP and the need for continuous improvements of the NLCSP in South Korea.
Abstract
Background/Aims: The National Liver Cancer Surveillance Program (NLCSP) was established in 2003 to reduce the socioeconomic burden imposed by liver cancer (LC). We aimed to investigate the effectiveness of the NLCSP in South Korea with respect to survival benefits and cost, after adjusting for various confounding factors. Methods: We used the National Health Insurance Service claims data linked with the NLCSP from 2004 to 2015. The Cox proportional hazard model and generalized linear model were used to determine the effects of the NLCSP on the early detection of LC, survival, and medical costs. Results: From 2006 to 2010, 66,632 patients (surveillance group: 10,527 and no surveillance group: 56,105) newly diagnosed with LC were included in the study. The odds of the early detection of LC was 1.82 (95% confidence interval [CI], 1.73 to 1.93) times higher among patients who participated in the NLCSP once within the 2-year period prior to the diagnosis of LC than among those who did not participate in the surveillance program. The mortality rate of patients who participated in the NLCSP was 22.0% lower (hazard ratio, 0.78; 95% CI, 0.76 to 0.80) than that of those who did not participate. When compared with the group who did not participate in surveillance, the group who participated in the NLCSP had higher total medical costs; however, their cost per day was lower after adjustment during the follow-up period. Conclusions: This study highlights the survival benefit in patients who participated in the NLCSP and the need for continuous improvements of the NLCSP in South Korea.
참고문헌 (34)
- Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014", Cancer Research and Treatment, 49(2), pp.292~305 (2017), 대한암학회
- Altekruse SF, "Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005", J Clin Oncol, 27, pp.1485~1491 (2009)
- Balogh J, "Hepatocellular carcinoma : a review", J Hepatocell Carcinoma, 3, pp.41~53 (2016)
- Zhao C, "Hepatocellular carcinoma screening and surveillance : practice guidelines and real-life practice", J Clin Gastroenterol, 50, pp.120~133 (2016)
- Mittal S, "Effectiveness of surveillance for hepatocellular carcinoma in clinical practice : a United States cohort", J Hepatol, 65, pp.1148~1154 (2016)
- Schweitzer A, "Estimations of worldwide prevalence of chronic hepatitis B virus infection : a systematic review of data published between 1965 and 2013", Lancet, 386, pp.1546~1555 (2015)
- Petruzziello A, "Global epidemiology of hepatitis C virus infection : an up-date of the distribution and circulation of hepatitis C virus genotypes", World J Gastroenterol, 22, pp.7824~7840 (2016)
- Kudo M, "Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan", Liver Cancer, 4, pp.39~50 (2015)
- Kudo M, "Japan’s successful model of nationwide hepatocellular carcinoma surveillance highlighting the urgent need for global surveillance", Liver Cancer, 1, pp.141~143 (2012)
- Yoon SK, "Status of hepatocellular carcinoma in South Korea", Chin Clin Oncol, 2, pp.39~ (2013)
- Omata M, "Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma : a 2017 update", Hepatol Int, 11, pp.317~370 (2017)
- 서미나, "Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012", Cancer Research and Treatment, 49(3), pp.798~806 (2017), 대한암학회
- 이영화, "Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea", Cancer Research and Treatment, 46(3), pp.223~233 (2014), 대한암학회
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Schwartz M, "A biomathematical approach to clinical tumor growth", Cancer, 14, pp.1272~1294 (1961)
- Cho EJ, "Surveillance for hepatocellular carcinoma may improve patient survival even in patients with decompensated cirrhosis", Proceedings of the 2012 the Korean Association for the Study of the Liver Meeting (2012)
- Edenvik P, "Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice", Liver Int, 35, pp.1862~1871 (2015)
- van Meer S, "Surveillance for hepatocellular carcinoma is associated with increased survival : results from a large cohort in the Netherlands", J Hepatol, 63, pp.1156~1163 (2015)
- El-Zayadi AR, "Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients", Hepatol Int, 4, pp.500~506 (2010)
- Nusbaum JD, "The effect of hepatocellular carcinoma surveillance in an urban population with liver cirrhosis", J Clin Gastroenterol, 49, pp.e91~e95 (2015)
- Kim HY, "Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area", Aliment Pharmacol Ther, 47, pp.1490~1501 (2018)
- El-Serag HB, "Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA", Gut, 60, pp.992~997 (2011)
- Tanaka H, "Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival", Liver Int, 26, pp.543~551 (2006)
- Tong MJ, "Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B : results from a community-based clinic", Dig Dis Sci, 55, pp.826~835 (2010)
- Wong GL, "Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis", Liver Int, 28, pp.79~87 (2008)
- Cucchetti A, "Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma", J Hepatol, 61, pp.333~341 (2014)
- Duffy SW, "Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival", Am J Epidemiol, 168, pp.98~104 (2008)
- Bruix J, "Management of hepatocellular carcinoma: an update", Hepatology, 53, pp.1020~1022 (2011)
- European Association for the Study of the Liver, "EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma", J Hepatol, 56, pp.908~943 (2012)
- Sheu JC, "Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications", Gastroenterology, 89, pp.259~266 (1985)
- Davila JA, "Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States", Ann Intern Med, 154, pp.85~93 (2011)
- Singal AG, "Improving hepatocellular carcinoma screening : applying lessons from colorectal cancer screening", Clin Gastroenterol Hepatol, 11, pp.472~477 (2013)
- Otto SJ, "Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer : self-selection bias", J Med Screen, 11, pp.89~92 (2004)